Dr. Reddy's Lab gets EIR from USFDA for manufacturing plants at Visakhapatnam
13th Sep 2019

Dr. Reddy's Laboratories has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for formulations manufacturing plants at Visakhapatnam. The agency had conducted an audit of the company’s formulations manufacturing plants (Vizag SEZ Plant 1 - FTO 7 and Vizag SEZ Plant 2 - FTO 9) at Duvvada, Visakhapatnam, which was completed on June 21, 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.